Tiancen Hu

Antibody Engineer at ViiV

[Chun-Li Zhang @ZhangLab_UTSW]

Revisiting astrocyte to neuron conversion with lineage tracing in vivo.
https://t.co/BkCwMVhufE

[Hoy Shen @HoyShen]

The First paper from the #Shenlab at #yale, SLC25-targeting dual CRISPR screen + functional analysis to deorphanize SLC25A39 in mitochondrial GSH import. (1/n)

[MatTek Life Sciences @MatTekLifeSci]

Sending our Valentine love to all you scientists out there💚

Image by @HoyShen at Yale University on a MatTek Dish.

[Antibody Engineering @AntibodyEngIC]

Our latest report looks at the success, targets, challenges and technologies of different antibody therapeutic https://t.co/K78KonsEPO or download it here https://t.co/83G3xbOLaO

[Tiancen Hu @TiancenHTC]

@ZhinanX @ChineseAntibody A target on cancer stem cell, receptor involved in Wnt signaling.

[Hoy Shen @HoyShen]

Most transformative meds originate in curiosity-driven science, evidence says https://t.co/KZzKeMoImJ via @Harvard

[Perrimon Lab @PerrimonLab]

Technical breakthrough: A library of 500 million camelid antibodies using yeast cells: https://t.co/Oq5W3XBdaD

[Nature Portfolio @NaturePortfolio]

A study published in Nature describes a wood densification method that combines a chemical treatment with high-temperature compression to produce an unprecedented increase in stiffness and strength. This News & Views article discusses the findings https://t.co/2w3ZnBhtaz

[David J Glass MD @davidjglassMD]

Here's a new paper on GDF11 from us...

Supraphysiologic Administration of GDF11 Induces Cachexia in Part by Upregulating GDF15

https://t.co/ksiw1niW9S

[Alastair McAlpine, MD @AlastairMcA30]

For an assignment, I asked some of my terminal paediatric palliative care patients what they had enjoyed in life, and what gave it meaning. Kids can be so wise, y'know. Here are some of the responses (Thread).

[eLife - the journal @eLife]

Reviewer 2 agreed that the ability to determine structures directly within the cellular environment "will transform structural cell biology" https://t.co/KhqA7AUZs5 #ResearchAdvance